Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of Milvexian in ESRD Patients on Hemodialysis
NCT03000673Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- May 2017
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of milvexian in thrombosis, sponsored by Bristol Myers Squibb. Started May 2017; status: completed.
02
Drugs
milvexian
03
Conditions
thrombosis
Beyond the preview
Go deeper on NCT03000673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03000673.